Innovation boosts R&D outlook despite COVID difficulties – reportAyming Group’s second annual International Innovation Barometer (IIB) has said that the international outlook for R&D is “remarkably Share XInnovation boosts R&D outlook despite COVID difficulties – reporthttps://pharmaphorum.com/r-d/views-analysis-r-d/innovation-boosts-rd-outlook-despite-covid-difficulties-report/
Unpleasant truth: the pandemic, record debt and our opportunity for sustainabilitySandoz’s Pierre Bourdage looks at the unexpected secondary impacts of COVID-19 on countries and healthcare systems, and asks Share XUnpleasant truth: the pandemic, record debt and our opportunity for sustainabilityhttps://pharmaphorum.com/views-analysis-digital/unpleasant-truth-pandemic-record-debt-sustainability/
AstraZeneca: pharma needs to lead by example on sustainabilityPaul Tunnah sat down with AstraZeneca’s vice president of sustainability strategy and engagement Jim Massey to discuss how Share XAstraZeneca: pharma needs to lead by example on sustainabilityhttps://pharmaphorum.com/views-analysis-sales-marketing/astrazeneca-pharma-needs-to-lead-by-example-on-sustainability/
